ArticleCell cycle (Georgetown, Tex.)2018

Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Kei Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.